CYTK Tambahing bathi saben saham ing taun lumaku Cytokinetics

CYTK (Cytokinetics Corp) - tandha merek perusahaan

Geopolitical disruptions and national isolation hinder global testing and the import of biomaterials for Cytokinetics (CYTK). The annual EPS volatility chart illustrates profit dynamics, where the value 8.50 represents the current figure. High R&D expenditures and dependence on the FDA create financial risks; however, the commercial launch of cardiology products will enable sales scaling and offset development costs.

Wutah bathi saben saham ing taun lumaku: Cytokinetics Inc. (CYTK) kanggo 04.07.2022 - 12.11.2026

Rincian metrik keuangan lan pasar Cytokinetics (CYTK)

- nilai pasar lan prakiraan target analis:
Rega saham Cytokinetics Inc.|CYTK - Bagan rega target
- data kapitalisasi pasar:
Nilai pasar Cytokinetics Corp|CYTK - Nilai Total Perusahaan
- rincian valuasi buku bisnis:
Nilai Aset Bersih saben Saham Cytokinetics|CYTK - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku cytokinetics.com|CYTK - Aset Agregat Perusahaan
- rincian utang lan likuiditas:
Utang marang Modal Cytokinetics|CYTK - Utang jangka dawa marang modal|Tanggungan utang jangka cendhak marang ekuitas cytokinetics.com|CYTK - Gunggung utang perusahaan|Utang-utang marang nilai buku Cytokinetics Corp|CYTK - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Cytokinetics|Likuiditas darurat cytokinetics.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
CYTK - Penghasilan resik|Bathi resik mangsa ngarep Cytokinetics|CYTK - Rasio rega marang bathi|Rasio prakiraan rega marang bathi Cytokinetics Corp|CYTK - Rasio rega marang bathi tumrap wutah|Pangali EV/EBITDA Cytokinetics Corp|CYTK - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Cytokinetics|CYTK - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan cytokinetics.com|CYTK - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Cytokinetics
Ringkesan analisis perusahaan:CYTK Cytokinetics Inc.
Produk mawa merek Cytokinetics

This indicator tracks the year-over-year dynamics of earnings per share, allowing for an assessment of business capitalization efficiency relative to previous periods. By analyzing the annual EPS growth trajectory, an investor can discern profit sensitivity to macro shifts, which for Cytokinetics (CYTK) directly reflects the scientific team's success in achieving key clinical results and implementing the researcher incentive system.

Pesaing langsung

Jazz Pharmaceuticals PLC (JAZZ) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun lumaku PTC Therapeutics Corp|SRRK: Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Centessa Pharmaceuticals (CNTA)|DYN - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Edgewise Therapeutics, Inc. EWTX|Rapport Therapeutics Inc - Wutah bathi saben saham ing taun lumaku|ALMS - Wutah bathi saben saham ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Zevra Corp|CTNM: Wutah bathi ing taun lumaku|Owah-owahan bathi resik saben saham ing taun lumaku larimartx.com LRMR|Wutah bathi resik saben saham ing taun iki CAPR|Kacepetan wutah bathi saben saham ing taun lumaku Entrada Therapeutics Inc. TRDA|Wutah bathi ing taun lumaku PTHS|Wutah bathi resik saben saham ing taun iki medicinova.com MNOV|Serina Therapeutics, Inc. - Wutah bathi resik saben saham ing taun iki|bioxceltherapeutics.com (BTAI) - Kacepetan wutah bathi saben saham ing taun lumaku|PMN: Wutah bathi resik saben saham ing taun iki|Apimeds Pharmaceuticals - Wutah bathi resik saben siji saham kanggo taun lumaku|aeonbiopharma.com (AEON) - Wutah bathi saben saham ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku NLS Pharmaceutics (NLSP)|Wutah bathi saben saham ing taun lumaku Bionomics Ltd.|Wutah bathi ing taun lumaku fsdpharma.com|Wutah bathi ing taun lumaku RETA